Replacing 20% of global beef consumption with fermentation-derived microbial protein by 2050 could halve annual deforestation and associated carbon dioxide emissions.

The biopharmaceutical company Biomunex Pharmaceuticals announces the appointment of Dr Simon Plyte as Chief Scientific Officer (CSO) and as a member of its scientific advisory board.

Deutsche Börse report key growth figures of the German biotech sector in 2021 in BIOTECH Insight, its new online information service published in collaboration with BIOCOM AG.

Cancer specialist Engimmune Therapeutics has raised CHF15.5m in a seed financing to expand its pipeline of T-cell receptor therapeutics.

The Swiss Biotech sector has again attracted record-breaking investments in 2021, according to the Swiss Biotech Report that was presented at the Swiss Biotech Day 2022 in Basel.

The EchoLUTION Tissue DNA Kit from BioEcho was developed to isolate high-quality DNA in a short time, even from difficult-to-extract samples such as muscle and adipose tissue. Due to the significantly shorter lysis and reduced number of steps, the entire workflow is three to ten times faster than conventional methods that follow the bind-wash-elute principle.

Digital medicine holds great opportunities. The EU Commission is therefore presenting a draft law this week that defines rules for a European Health Data Space.

The rapid growth of active pharmaceutical ingredients (APIs) has led to more biotech companies enlisting the support of strategic partners to navigate the regulatory environment and bring their innovative products to market.

Swiss and Swedish researchers have uncovered four previously unkown autoantigens that trigger multiple sclerosis in mice.